B. A. Antmen Et Al. , "The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor," JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13, pp.861, 2015
Antmen, B. A. Et Al. 2015. The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13 , 861.
Antmen, B. A., Sasmaz, I., Karagun, B. Ş., LEBLEBİSATAN, G., KILINÇ, Y., Aridogan, A., ... YAZICIOĞLU, İ.(2015). The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13, 861.
Antmen, B. Et Al. "The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor," JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13, 861, 2015
Antmen, B. A. Et Al. "The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor." JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13, pp.861, 2015
Antmen, B. A. Et Al. (2015) . "The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor." JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.13, p.861.
@article{article, author={B. A. Antmen Et Al. }, title={The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor}, journal={JOURNAL OF THROMBOSIS AND HAEMOSTASIS}, year=2015, pages={861} }